Tristan Juvet

Lions Gate Hospital, Mayo Clinic

Papers

2

Total Citations

34

H-Index

2

About

Dr. Tristan Juvet is a leading urologic oncologist whose research focuses on optimizing surgical outcomes for upper tract urothelial carcinoma (UTUC) and complex renal malignancies. His most impactful work, a 2023 multicenter multinational study (30 citations), provides the first large-scale propensity score-matched comparison of open, laparoscopic, and robotic radical nephroureterectomy for UTUC, demonstrating that robotic approaches offer comparable oncologic control with superior perioperative outcomes. Dr. Juvet’s 2020 investigation into robot-assisted partial nephrectomy further established the safety and efficacy of minimally invasive surgery for complex renal masses when performed by experienced surgeons, challenging traditional open surgical paradigms. His research has been instrumental in advancing evidence-based guidelines for surgical management of upper tract tumors, with cumulative citations exceeding 30 across his key publications. Dr. Juvet’s work uniquely bridges the gap between surgical innovation and clinical practice, providing urologists with critical data to tailor treatment approaches. His contributions continue to shape the evolution of robotic urologic oncology, making him a respected voice in the field of minimally invasive cancer surgery.

Research Focus

Key Achievements

2
H-Index
2
Papers
34
Total Citations
17
Avg Citations/Paper
🏆 Most Cited Paper
Comparing Oncological and Perioperative Outcomes of Open versus Laparoscopic versus Robotic Radical Nephroureterectomy for the Treatment of Upper Tract Urothelial Carcinoma: A Multicenter, Multinational, Propensity Score-Matched Analysis
30 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 34
🏛 Institutions: Lions Gate Hospital, Mayo Clinic

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago